2017年上半年内蒙古临床医学检验技术相关专业知识试题.pdf
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_1.gif)
![资源得分’ title=](/images/score_05.gif)
《2017年上半年内蒙古临床医学检验技术相关专业知识试题.pdf》由会员分享,可在线阅读,更多相关《2017年上半年内蒙古临床医学检验技术相关专业知识试题.pdf(8页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、2017 年上半年内蒙古临床医学检验技术相关专业知识试题一、单项选择题共27 题,每题的备选项中,只有1 个事最符合题意1、用于溶血反应和补体结合试验的稀释缓冲液,除了含有适量的氯化钠和具有一定的 pH 外,还需含有少量A钾离子B钙离子和镁离子C铜离子D铁离子E钠离子2、人类感染恙虫病立克次体的最主要传播途径是A节肢动物叮咬B输血C吸入气溶胶D摄入污染食物E母婴垂直传播3、白细胞数小于 2109/L,采用以下方法中哪项是错误的?A重新采血复查B取血量 20μl 改为 40μlC可数 8 个大方格白细胞数结果乘2D结合分类涂片细胞分布综合判断E以上都是错误的4、不符合急性单核细胞性白
2、血病细胞染色结果的是A-NAE:阳性,不被 NaF抑制BAS-D-NCE:阴性CAS-D-NAL:阳性,被 NaF 抑制D-NBE:阳性,被 NaF 抑制EPOX:弱阳性或阳性5、自动生化分析仪按反应装置的结构分类可分为A流动式和分立式B单通道和多通道C大型,中型和小型D离心式和分立式E离心式和流动式6、来源于黄铁矿矿石的药材是A信石B朱砂C自然铜D赭石E雄黄7、作为过筛试验的分析方法一般要求有A高灵敏度B高特异性C重复性好D总有效率高E准确度高8、乙醇在片剂制备中可作为哪种辅料A润滑剂B润湿剂C助流剂D稀释剂E黏合剂9、黑膏药制备工艺的关键工序是A提取药料B炼油C下丹D去“火毒”E摊涂药膏1
3、0、以下有关抗原抗体反应特点的表达中,错误的选项是A抗原抗体的反应具有特异性B抗原抗体只有在分子比例合适时才会出现最强的反应C反应曲线中,抗原抗体分子比例合适的范围称为等价带D抗原抗体的反应具有不可逆性E抗原,抗体具有特异的结合部位11、中性粒细胞碱性磷酸酶积分值降低的疾病是A骨髓纤维化B蜂窝组织炎C急性粒细胞白血病D慢性淋巴细胞白血病E慢性粒细胞白血病急变期12、有关沉淀反应的表达,不正确的选项是A沉淀反应的抗原多是颗粒性物质B抗原与相应抗体结合的第一阶段十分快速,但不可见C沉淀反应的抗原多是可溶性抗原D第二阶段形成大的可见的免疫复合物E第二阶段通常需几十分钟到数小时完成13、新生 HDL
4、向成熟 HDL 转化需要A磷脂不断进入 HDL 核心层B胆固醇酯不断进入HDL 核心层C游离脂肪酸不断进入HDL 核心层D甘油三酯不断进入HDL 核心层E胆固醇不断进入HDL,核心层14、pH 计中的电极是属于下述中的哪一种_A晶体电极B气敏电极C玻璃电极文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码
5、:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5
6、O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6
7、 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9
8、O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T
9、1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H
10、10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4
11、W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5D酶电极E流动载体电极15、以 2 种浓度的质控物对某检验项目进行室内质控时,以下图形中箭头所指的“点”违背 Westgard多规则质控方法的哪条质控规则A.41sB.13sC.22sD.10XbarE.R4s 16、亚胺类属于A直接致癌物B前致癌物C近致癌物D助致癌物E终致癌物17、关于组织相容性的表达正确的选项是指器官或组织移植时A供者与受者相互接受的程度,如相容则互不排斥,不相容则出现排斥反应B供者与受者相互排斥的程度C供者与受者大小相适合的程度D供者与受者的免疫状态E仅指供者的免疫状态18、L3 型
12、急性淋巴细胞白血病的细胞学特征是A小细胞为主,大小较一致B核染色质较粗,每例结构较一致C核仁明显,个或多个,呈小泡状D胞质量较少E胞质嗜碱性轻或中度19、成人“少尿”指 24h 尿量少于A0.1LB0.2LC0.3LD0.4LE1L 20、急性红白血病以下哪项是错误的A外周血可见幼红和幼粒细胞B幼红细胞 POX 阳性C幼红细胞有巨幼样变D幼红细胞糖原染色阳性明显增高E骨髓红系明显增生21、Raji 细胞的外表标志除了有C3b受体,没有 SmIg 外,其他是A有 C1q 受体,无 C3d 受体B有 C1q受体,有 C3d 受体C无 C1q 受体,无 C3d 受体D无 C1q 受体,有 C3d 受
13、体文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:
14、CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O
15、1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6
16、HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O
17、4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1
18、 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H1
19、0I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5E无 C1q 受体,有 C3a受体22、使纤维蛋白分解为纤维蛋白降解产物的是_A凝血酶B抗凝血酶CFD纤维蛋白单体E纤溶酶23、属于 SLE 特征性标志抗体的是A抗
20、SS-DNA 和抗 Sm 抗体B抗 SS-DNA 和抗 ds-DNA 抗体C抗 ds-DNA 和抗 Sm 抗体D抗 ENA 和抗 Sm 抗体E抗 ENA 和抗 ds-DNA 抗体24、以下哪项不是血管壁的止血功能A引起血管收缩B释放促凝物质C激活血小板D激活凝血途径E引起局部血液粘度下降25、以下属于免疫放射分析特征的是A核素标记在抗体分子上B竞争性免疫分析C均相免疫分析D体系中抗体限量E常选用 2H 作为标记物26、病毒的特征是A个体极小B没有细胞结构C专性细胞内寄生D以复制方式增殖E以上均是27、正常人体生物转化过程最重要的作用是A使药物失效B使生物活性物质灭活C使非极性化合物变为极性化合
21、物,利于排出体外D使毒物毒性降低E使某些药物药性更强或毒性增加二、多项选择题 共 27 题,每题的备选项中,有 2 个或 2 个以上符合题意,至少有 1 个错项。1、布鲁菌感染的发热类型是A稽留热B波浪热C弛张热D低热文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O
22、4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1
23、 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H1
24、0I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W
25、5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:CD2A5O1G1V6 HK5J9O4T10T1 ZA9H10I8I4W5文档编码:
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 2017 上半年 内蒙古 临床医学 检验 技术 相关 专业知识 试题
![提示](https://www.taowenge.com/images/bang_tan.gif)
限制150内